The ROC analyses, even performed on a limited number of samples, identified the cut-off levels of CDH1, CDH5, and ZEB1 genes useful for the possible diagnostic identification of primary or metastatic tumors. The gene discussed is CDH1; the disease is metastatic neoplasm.